Supplements for H Pylori: Bioavailability, Stack Synergies, and Lab-Backed Dosing

Why Nutritional Support Matters During H. Pylori Treatment

Helicobacter pylori is a gram-negative, microaerophilic bacterium that colonizes the gastric mucosa in approximately 44% of the global population (Hooi et al., Gastroenterology 2017; PMID: 28456631). Standard eradication uses clarithromycin-based triple therapy or bismuth quadruple therapy, but first-line eradication rates have fallen below 80% in many regions due to antibiotic resistance (Graham & Fischbach, Gut 2010; PMID: 20551508). That gap is precisely where evidence-based supplements for H pylori enter the clinical picture.

Nutritional and botanical compounds can contribute to treatment in three distinct ways: (1) direct antimicrobial or anti-adhesion activity against H. pylori, (2) reinforcement of the gastric mucosal barrier that the bacterium erodes, and (3) restoration of microbiome diversity disrupted by broad-spectrum antibiotics. Understanding these mechanisms — and which ingredients operate through each one — is the foundation of an effective stack.

Before adjusting any supplement regimen alongside antibiotic therapy, consult a licensed gastroenterologist or functional medicine physician. Lab confirmation (urea breath test, stool antigen, or endoscopic biopsy) should guide both treatment initiation and post-treatment verification.

---

The Core Evidence-Based Ingredients

1. Mastic Gum (Pistacia lentiscus)

Mastic gum is the most studied botanical for H. pylori. A randomized controlled trial by Huwez et al. (New England Journal of Medicine 1998; PMID: 9853574) demonstrated that 1 g/day of mastic gum for two weeks eradicated H. pylori in 3 of 10 patients versus 0 of 10 controls — a foundational result that sparked subsequent investigation. Later in vitro work confirmed that mastic's triterpenoid fraction, particularly oleanolic acid, disrupts bacterial cell membranes and inhibits DNA gyrase (Marone et al., Journal of Chemotherapy 2001; PMID: 11548441).

Effective clinical dose: 1,000–2,000 mg/day, taken on an empty stomach, split into two doses.

2. Sulforaphane (from Broccoli Sprout Extract)

Sulforaphane, the isothiocyanate derived from glucoraphanin in cruciferous vegetables, exhibits potent bactericidal activity against H. pylori, including clarithromycin-resistant strains. A human pilot study by Haristoy et al. (Antimicrobial Agents and Chemotherapy 2003; PMID: 12936982) showed significant reductions in H. pylori colonization in infected mice after sulforaphane administration. Subsequent Phase II human data from Yanaka et al. (Cancer Prevention Research 2009; PMID: 19349290) found that daily consumption of broccoli sprouts rich in glucoraphanin for 8 weeks significantly reduced H. pylori colonization markers (urease activity, serum pepsinogen I/II ratio) versus alfalfa sprout controls.

Effective clinical dose: 14–28 mg of sulforaphane daily (typically delivered as 250–500 mg standardized broccoli sprout extract).

3. Probiotics — Lactobacillus reuteri and Saccharomyces boulardii

Probiotics may be the most practically impactful category of supplements for H pylori because they address two problems simultaneously: competing against the bacterium itself and preventing antibiotic-associated diarrhea. A meta-analysis of 30 RCTs (Li et al., European Journal of Gastroenterology & Hepatology 2016; PMID: 26950766) found that adding probiotics to standard triple therapy improved eradication rates by approximately 10–14 percentage points and significantly reduced side-effect rates.

Lactobacillus reuteri strains DSM 17938 and ATCC PTA 6475 appear to suppress H. pylori via reuterin production and competitive colonization. Saccharomyces boulardii (250–500 mg twice daily) reduces antibiotic-associated diarrhea risk by preserving intestinal IgA secretion.

Timing matters: Probiotics should be taken at least 2 hours away from antibiotics to maximize viable colony delivery.

4. Zinc-Carnosine (Polaprezinc)

Zinc-L-carnosine is a chelated compound with unique gastroprotective properties — the zinc and carnosine dissociate slowly in the stomach, providing prolonged mucosal contact. A double-blind RCT by Suzuki et al. (Alimentary Pharmacology & Therapeutics 2009; PMID: 19549266) demonstrated that polaprezinc (150 mg/day) added to triple therapy improved H. pylori eradication rates compared to triple therapy alone and reduced gastric mucosal inflammation scores. The carnosine fraction appears to act as a free-radical scavenger in the oxidative microenvironment created by H. pylori infection.

Effective clinical dose: 75–150 mg twice daily with meals.

5. Vitamin C (Ascorbic Acid)

Gastric juice ascorbic acid is significantly depleted in H. pylori-infected individuals. Two epidemiological analyses have linked low gastric ascorbic acid to elevated gastric cancer risk in this population (Correa et al., Journal of the National Cancer Institute 2000; PMID: 10601386). Mechanistically, vitamin C inhibits H. pylori's urease activity and may reduce the mutagenic N-nitroso compound formation that the bacteria catalyze in the stomach. High-dose oral vitamin C (1,000–2,000 mg/day with meals) is a low-cost, low-risk adjunct in most H. pylori protocols.

6. Lactoferrin

Lactoferrin, an iron-binding glycoprotein found in colostrum and milk whey, destabilizes the outer membrane of gram-negative bacteria by chelating iron — a nutrient H. pylori requires for growth. A meta-analysis by Sachdeva & Nagpal (Nutrition 2009; PMID: 19101123) pooled data from four RCTs and found that bovine lactoferrin supplementation (200–300 mg/day) significantly improved eradication rates when added to standard therapy.

---

Functional Medicine Supplements and the Root-Cause Framework

A functional medicine approach to H. pylori does not stop at killing the bacterium — it asks why the gastric environment became permissive to colonization in the first place. Functional medicine supplements typically address upstream drivers: hypochlorhydria (low stomach acid), compromised mucosal immunity, and systemic inflammation.

Key adjunct compounds in this broader functional framework include:

• DGL (Deglycyrrhizinated Licorice): Stimulates mucin synthesis and supports the gastric mucus layer. A study by Morgan et al. (Gut 1982; PMID: 7076900) demonstrated equivalent efficacy to cimetidine for duodenal ulcer healing, and DGL avoids the aldosterone-raising effects of whole licorice root. Standard dose: 380–760 mg before meals.
• Slippery Elm Bark: Demulcent properties coat irritated gastric mucosa. While robust RCT data are limited, it is widely included in integrative GI protocols for its mucilage content.
• Berberine: Demonstrates in vitro inhibitory activity against H. pylori and has the added benefit of supporting healthy blood sugar and gut microbiome diversity (Chu et al., Phytotherapy Research 2018; PMID: 30058192).

This root-cause orientation distinguishes functional medicine supplementation from simple symptom management — and it aligns naturally with how platforms like Ones analyze a user's full lab picture, including markers like gastrin, pepsinogen I/II ratios, and inflammatory CRP, before building a custom formula.

---

Bioavailability and Timing: Making the Stack Work

The best ingredient at the wrong time or in the wrong form delivers a fraction of its potential. Here are the key bioavailability principles for an H. pylori stack:

For individuals running a full eradication protocol, a typical daily sequencing might look like:

1. Morning (empty stomach): Mastic gum 1,000 mg + Lactoferrin 300 mg
2. Breakfast: Sulforaphane extract, Vitamin C 500 mg, Zinc-Carnosine 75 mg
3. Mid-morning (2 hrs post-antibiotic): Probiotic blend
4. Before lunch: DGL chewable tablet
5. Dinner: Zinc-Carnosine 75 mg, Vitamin C 500 mg
6. Evening (2 hrs post-antibiotic): Second probiotic dose

---

Stack Synergies: What Pairs Well Together

Certain ingredient combinations produce effects that exceed what either component achieves individually:

• Mastic Gum + Sulforaphane: Both are bactericidal via different mechanisms (membrane disruption vs. intracellular stress induction), making resistance development less likely and potential synergy plausible — though head-to-head combination RCTs remain limited.
• Zinc-Carnosine + Vitamin C: Zinc supports tissue repair and immune function at the mucosal level; vitamin C regenerates oxidized antioxidants and independently inhibits urease. Together they address both the inflammatory and oxidative damage H. pylori inflicts.
• Probiotics + Lactoferrin: Lactoferrin creates a less hospitable iron environment for H. pylori while probiotics competitively colonize available niches. A combination RCT by Zullo et al. (Helicobacter 2005; PMID: 16109147) found improved eradication rates with this pairing added to triple therapy.

For deeper context on how micronutrient deficiencies interact with gut health, see our guide to vitamin D3 and immune support for gut integrity — vitamin D receptors are expressed throughout the GI tract and deficiency correlates with mucosal vulnerability.

---

How Ones Addresses This

Ones approaches H. pylori support not as a one-size-fits-all gut supplement protocol, but as a data-driven formula built around your specific lab markers and health history. When your intake includes elevated inflammatory markers, documented gastric symptoms, or antibiotic history, the Ones AI practitioner can incorporate several clinically relevant ingredients:

• Zinc (as Zinc Glycinate or Zinc Carnosine complex): Ones includes zinc at clinically meaningful doses to support both mucosal repair and immune surveillance. Zinc deficiency is common in H. pylori patients due to impaired gastric acid reducing mineral absorption — a feedback loop the formula directly addresses.
• Vitamin C (as Ascorbic Acid): Available as part of Ones' Immune-C System Blend, which delivers vitamin C alongside immune-relevant cofactors. Given the established depletion of gastric ascorbate in H. pylori infection and its role in inhibiting urease, this is a natural fit for affected individuals.
• Magnesium Complex: Ones' Magnesium Complex blend includes magnesium glycinate, a highly bioavailable form that supports smooth muscle relaxation and gut motility — both of which are often dysregulated during and after H. pylori infection. Explore the optimal magnesium glycinate dosage for gut and sleep support for additional context.

Because Ones formulas are built on a capsule budget (6, 9, or 12 capsules), the platform intelligently prioritizes the ingredients most supported by your labs — so someone with confirmed H. pylori history and low serum zinc gets a meaningfully different formula than someone with a clean GI history but high stress markers.

If you're navigating concurrent gut and systemic issues, the clinical evidence for ashwagandha in stress and gut axis support is worth reviewing — the gut-brain axis is a real and measurable factor in gastric mucosal health.

---

Key Takeaways

• H. pylori eradication rates with antibiotics alone are declining due to antibiotic resistance; evidence-based supplements can improve eradication rates by 10–14 percentage points when added to standard therapy.
• The most clinically supported ingredients are mastic gum (1–2 g/day), sulforaphane (14–28 mg/day), zinc-carnosine (150 mg/day), probiotics (L. reuteri, S. boulardii), vitamin C (1–2 g/day), and lactoferrin (200–300 mg/day).
• Timing and form matter enormously — mastic gum is most effective on an empty stomach, DGL requires chewable format for mucosal contact, and probiotics must be separated from antibiotics by at least 2 hours.
• A functional medicine framework looks beyond bacterial eradication to restore gastric acid adequacy, mucosal immunity, and microbiome diversity — the conditions that prevented resilience against colonization in the first place.
• Synergistic stacking (e.g., zinc-carnosine + vitamin C, mastic gum + sulforaphane, probiotics + lactoferrin) leverages complementary mechanisms and may reduce the likelihood of resistance.
• Ones personalizes supplement formulas based on your lab data — including gut-relevant markers — ensuring that ingredients like zinc, vitamin C, and magnesium are included at doses calibrated to your actual deficiency profile, not population averages.